Mobile Sipoo is a randomized controlled trial aiming to improve selfcare and outcomes of diabetes and hypertensive patients by introducing a remote patient monitoring system supported with automatic patient decision support. The feedback system is coupled with back-office health coaching.

Self-monitored data from blood pressure meters (SMBP), glucometers (SMBG), scales and pedometers are transferred by mobile phone terminals to a tethered personal health record (PHR) integrated with the provider EHR. The PHR application includes tools to display of self-monitoring data.

Inclusion Criteria:

• Confirmed diagnosis of diabetes or hypertension made at least 6 months prior to inclusion to study.
• For hypertensive patients: Blood pressure over 140/90 mmHg (systolic and diastolic separately) treated or untreated
• Diabetes patients: Glycohemoglobin A1c over 6.5% but lower that 11%
• use of diabetes medication

Exclusion Criteria:

• Patients who decline to participate
• Patients specifically excluded by the health centre physician
• Patients unable to co-operate, expected poor study compliance (IT illiterate) or reluctance to perform self monitoring
• Pregnancy
• Patients with a life expectance of less than one year
• Patients with major elective surgery planned within 6 months or patient has had major surgery within last 2 months.
• Patients with psychiatric disorders (depression), abuse of alcohol or narcotics complicating or disabling participation in the study